0001209191-23-016098.txt : 20230303 0001209191-23-016098.hdr.sgml : 20230303 20230303210703 ACCESSION NUMBER: 0001209191-23-016098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wellman Kristine M CENTRAL INDEX KEY: 0001948665 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 23707314 MAIL ADDRESS: STREET 1: C/O THE CHEMOURS COMPANY STREET 2: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-01 0 0001627223 Chemours Co CC 0001948665 Wellman Kristine M C/O THE CHEMOURS COMPANY 1007 MARKET STREET WILMINGTON DE 19801 0 1 0 0 SVP, GC & Corp. Secretary Common Stock 2023-03-01 4 F 0 1088 34.84 D 22471.817 D Common Stock 2023-03-01 4 A 0 4664 0.00 A 27135.817 D Common Stock 2023-03-02 4 F 0 517 36.12 D 26618.817 D Stock Option (Right to Buy) 34.84 2023-03-01 4 A 0 10579 0.00 A 2033-03-01 Common Stock 10579 10579 D Performance Stock Option (Right to Buy) 38.32 2023-03-01 4 A 0 10430 0.00 A 2033-03-01 Common Stock 10430 10430 D Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Includes directly owned shares, restricted stock units and dividend equivalent units. Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Represents a 10 percent premium above the closing price of the Company common stock on the date of grant /s/ Pauletta Brown, Attorney-in-Fact 2023-03-03